Fingerprint
Dive into the research topics of 'Should bevacizumab be continued beyond progression in colorectal cancer?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Should bevacizumab be continued beyond progression in colorectal cancer?
Axel Grothey, Dirk Arnold, Lee M. Ellis
Research output: Contribution to journal › Review article › peer-review